CRISPR Therapeutics AG's ticker is and the CUSIP is 00BDHF4K6.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2020 | $474,641,000 | +18.2% | 3,100 | -35.4% | 0.22% | +7.7% |
| Q3 2020 | $401,472,000 | -5.8% | 4,800 | -17.2% | 0.21% | -12.9% |
| Q2 2020 | $426,242,000 | +173169.1% | 5,800 | 0.0% | 0.24% | +45.5% |
| Q1 2020 | $246,000 | -30.3% | 5,800 | 0.0% | 0.16% | -11.3% |
| Q4 2019 | $353,000 | +87.8% | 5,800 | +45.0% | 0.19% | +55.0% |
| Q2 2019 | $188,000 | – | 4,000 | – | 0.12% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|